AzTrials
AzTrials

Virtual Reality Based TherapyNCT03144102

Combining tDCS With VR-based Motor Training in Stroke

A study testing Virtual Reality-based therapy for upper-limbs motor rehabilitation, Anodal transcranial direct-current stimulation (tDCS) and Occupational Therapy for upper-limbs motor rehabilitation in people with Virtual Reality Based Therapy and Anodal tDCS, run by Universitat Pompeu Fabra at 1 site in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Stroke represents one of the main causes of adult disability and will be one of the main contributors to the burden of disease in 2030. However, our healthcare systems do not have enough resources to cover the current demand let alone its future increase. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Virtual Reality-based therapy for upper-limbs motor rehabilitation, Anodal transcranial direct-current stimulation (tDCS) and Occupational Therapy for upper-limbs motor rehabilitation
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
36 participants
Where
1 siteSpain
Study dates
15 May 2017to 8 Jun 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients with hemiparesis secondary to first ever ischemic or hemorrhagic stroke (Medical Research Council score > 2).
  • Older than 18 years old.
  • Sufficient cognitive capacity to understand and follow the experimental instructions (Mini-Mental State Evaluation > 20).

Who cannot join

  • Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data.
  • Epilepsia and metal implants. A diagnostic EEG will be performed by the Department of Clinical Neurophysiology of the hospital to detect epileptic paroxysmal in order to include or exclude patients in the study.
  • Low Cognitive capabilities that prohibits the execution of the experiment Arteriovenous malformation
  • Severe associated impairment such as spasticity, communication disabilities (sensorial, mixed or global aphasia or apraxia), major pain or other neuromuscular impairments or orthopaedic devices that would interfere with the correct execution of the experiment (Modified Ashworth Scale > 3)
  • History of serious mental-health problems in acute or sub acute phase
  • Refusal to sign the consent form
Show all 9Show fewer
  • Previous surgeries opening the skull.
  • Active or recent substance abuse or dependence within the past year.
  • Pregnancy, breastfeeding, unwillingness to practice birth control during participation in the study.

Trial locations and contacts

1 site in 1 country.

Paul Verschure, Prof. contact

0034935422202

paul.verschure@upf.edu

Belén Rubio, PhD contact

0034935422202

belen.rubio@upf.edu

Spain1 site, 1 recruiting
  • Unitat de Rehabilitació de l'Hospital Vall d'Hebron

    Barcelona, 08035

    Susana Rodríguez, Dr.

    Recruiting

Other trials in Spain

About this study

Official title: The Effects of Combining Transcranial Direct Current Stimulation (tDCS) With VR-based Motor Training in Hemiparetic Stroke Patients

Stroke represents one of the main causes of adult disability and will be one of the main contributors to the burden of disease in 2030. However, our healthcare systems do not have enough resources to cover the current demand let alone its future increase. There is a need to deploy new approaches that advance the current rehabilitation methods and enhance their efficiency.

One of the latest approaches used for the rehabilitation of a wide range of deficits of the nervous system is based on virtual reality (VR) applications, which combine training scenarios with dedicated interface devices. On the other hand, recent studies have shown the potential of transcranial direct current stimulation (tDCS) to restore motor function in hemiparetic stroke patients. It must be emphasized, however, that so far little work exists on the quantitative assessment of the clinical impact of VR based approaches in combination with tDCS protocols. We hypothesize that the combination of VR-based motor rehabilitation protocols with concurrent anodal tDCS can boost functional recovery, and may achieve superior effects when compared to 3 alternative treatments: 1) VR without tDCS, 2) occupational therapy with tDCS, and 3) occupational therapy without tDCS.

The findings derived from this study will contribute to establish a novel and superior neurorehabilitation paradigm that can accelerates the recovery of hemiparetic stroke patients. Besides the clinical impact, such achievement could have relevant socioeconomic impact.

Being tested
Virtual Reality-based therapy for upper-limbs motor rehabilitation, Anodal transcranial direct-current stimulation (tDCS), Occupational Therapy for upper-limbs motor rehabilitation, Sham transcranial direct-current stimulation (tDCS)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual Reality-based therapy for upper-limbs motor rehabilitationBehavioural

    During each session, the subject will perform 4 VR-based exercises that involve reaching, grasping, and intercepting virtual objects. The training will last a total of 30 min per session.

  • Anodal transcranial direct-current stimulation (tDCS)Device

    Concurrent anodal tDCS on sensorimotor cortex on the ipsilesional hemisphere.

  • Occupational Therapy for upper-limbs motor rehabilitationBehavioural

    During each session, the subject will perform 4 occupational therapy exercises that involve reaching, grasping, and intercepting objects. The training will last a total of 30 min per session.

  • Sham transcranial direct-current stimulation (tDCS)Device

    Concurrent sham tDCS on sensorimotor cortex on the ipsilesional hemisphere.

Study groups in NCT03144102
Study groupRoleWhat they receive
VR-based motor rehabilitation with tDCSExperimentalNot described
Receives: Behavioral: Virtual Reality-based therapy for upper-limbs motor rehabilitation; Device: Anodal transcranial direct-current stimulation (tDCS)
Occupational Therapy with tDCSActive comparatorNot described
Receives: Device: Anodal transcranial direct-current stimulation (tDCS); Behavioral: Occupational Therapy for upper-limbs motor rehabilitation
VR-based motor rehabilitation with sham tDCSSham comparatorNot described
Receives: Behavioral: Virtual Reality-based therapy for upper-limbs motor rehabilitation; Device: Sham transcranial direct-current stimulation (tDCS)
Occupational Therapy with sham tDCSSham comparatorNot described
Receives: Behavioral: Occupational Therapy for upper-limbs motor rehabilitation; Device: Sham transcranial direct-current stimulation (tDCS)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change of arm/hand function as captured by the upper extremity Fugl-Meyer assessment scale

    Measured: At baseline, at 2-weeks (after intervention), and at 8-weeks (follow-up)

Secondary outcomes (5)
  1. Change of Independence as captured by Barthel scale

    Measured: At baseline, at 2-weeks (after intervention), and at 8-weeks (follow-up)

  2. Change of motor function in ADLs as captured by Chedoke Arm and Hand Activity Inventory (CAHAI) scale

    Measured: At baseline, at 2-weeks (after intervention), and at 8-weeks (follow-up)

  3. Change of interhemispheric balance as captured by EEG recordings

    Measured: At baseline, at 2-weeks (after intervention), and at 8-weeks (follow-up)

  4. Change of spasticity in proximal and distal muscles as captured by Ashworth scale

    Measured: At baseline, at 2-weeks (after intervention), and at 8-weeks (follow-up)

  5. Change of spatial hemineglect as captured by the Star cancellation test

    Measured: At baseline, at 2-weeks (after intervention), and at 8-weeks (follow-up)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 May 2017
  2. Study start15 May 2017
  3. Primary completion8 Dec 2020 (estimated)
  4. Study completion8 Jun 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Factorial
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
36 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03144102
Sponsor's protocol ID
tDCSRGS
Status last verified
Aug 2020
First submitted
4 May 2017
Last updated
10 Aug 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Virtual Reality-based therapy for upper-limbs motor rehabilitation, Anodal transcranial direct-current stimulation (tDCS) and Occupational Therapy for upper-limbs motor rehabilitation in people with Virtual Reality Based Therapy and Anodal tDCS, run by Universitat Pompeu Fabra at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 Aug 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Paul Verschure, Prof. (0034935422202, paul.verschure@upf.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change of arm/hand function as captured by the upper extremity Fugl-Meyer assessment scale (time frame: At baseline, at 2-weeks (after intervention), and at 8-weeks (follow-up)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Aug 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in